Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2016.03.016PMID 27130863PMCID PMC4975951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis

  2015cited by this paper
• GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.

  2015cited by this paper
• Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa.

  2015cited by this paper
• Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency

  2015cited by this paper
• Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

  2014cited by this paper
• Early-onset stroke and vasculopathy associated with mutations in ADA2.

  2014cited by this paper
• Mutant ADA2 in vasculopathies.

  2014cited by this paper
• High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.

  2013cited by this paper
• Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.

  2012cited by this paper
• Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

  2011cited by this paper
• Identification of Specific Foods Responsible for Inflammation in Children With Eosinophilic Esophagitis Successfully Treated With Empiric Elimination Diet

  2011cited by this paper
• Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities.

  2009cited by this paper

• Early-onset neutropenia and mixed phenotype in ADA2 deficiency: diagnostic and therapeutic challenges

  2025cites this paper
• A Novel Mutation in the Adenosine Deaminase‐2 Gene Presenting as Severe Chronic Neutropenia With Myeloid Hypoplasia

  2025cites this paper
• Human ADA2 Deficiency: Ten Years Later

  2024cites this paper
• Vasculitis and vasculopathy associated with inborn errors of immunity: an overview

  2024cites this paper
• How I diagnose myeloid neoplasms with germline predisposition.

  2023cites this paper
• The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort

  2022cites this paper
• Haematopoietic stem cell transplantation in paediatric rheumatic disease

  2021cites this paper
• Adult-onset deficiency of adenosine deaminase 2—a case report and literature review

  2021cites this paper
• Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment

  2021cites this paper
• Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2)

  2021cites this paper
• Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations

  2021cites this paper
• Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure

  2021cites this paper
• Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency

  2021cites this paper
• Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

  2021cites this paper
• Dysregulation in B‐cell responses and T follicular helper cell function in ADA2 deficiency patients

  2020cites this paper
• A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α

  2020cites this paper
• Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).

  2020cites this paper
• Cutaneous nodules and livedo reticularis in a 3‐year‐old boy

  2020cites this paper
• Recent advances in primary immunodeficiency: from molecular diagnosis to treatment

  2020cites this paper
• Bone marrow failure syndromes

  2020cites this paper
• Inflammatory Manifestations of Systemic Diseases in the Central Nervous System

  2020cites this paper
• The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency

  2020cites this paper
• Adenosine Deaminase Type II Deficiency: Severe Chronic Neutropenia, Lymphoid Infiltration in Bone Marrow, and Inflammatory Features

  2020cites this paper
• Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2.

  2019cites this paper
• Identification et caractérisation de gènes impliqués dans les maladies auto-inflammatoires

  2019cites this paper
• Diagnosis and management of ADA2 deficient polyarteritis nodosa

  2019cites this paper
• Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.

  2019cites this paper
• Human adenosine deaminase 2 deficiency: A multi‐faceted inborn error of immunity

  2019cites this paper
• Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

  2019cites this paper
• A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2

  2019cites this paper
• Leveraging Genetic Findings for Precision Medicine in Vasculitis

  2019cites this paper
• [Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature].

  2018cites this paper
• Management of Humoral Primary Immunodeficiencies in Adults

  2018cites this paper
• Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2

  2018cites this paper
• Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment

  2018cites this paper
• Deficiency of Adenosine Deaminase 2 in Adult Siblings: Many Years of a Misdiagnosed Disease With Severe Consequences

  2018cites this paper
• ADA2 deficiency: Clonal lymphoproliferation in a subset of patients

  2018cites this paper
• Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure

  2018cites this paper
• Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders

  2017cites this paper
• Successful reduced intensity hematopoietic cell transplant in a patient with deficiency of adenosine deaminase 2

  2017cites this paper
• Les multiples facettes du déficit en ADA2, vascularite, maladie auto-inflammatoire et immunodéficit : mise au point à partir des 135 cas de la littérature

  2017cites this paper
• Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.

  2017cites this paper
• Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.

  2017cites this paper
• Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood

  2017cites this paper
• Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency

  2017cites this paper
• Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes

  2017cites this paper